Zoetis (ZTS) Long-Term Debt Issuances (2013 - 2025)

Zoetis (ZTS) posted quarterly Long-Term Debt Issuances of $152.0 million for Q4 2025, up 1281.82% quarter-over-quarter from $11.0 million in Q4 2018.

Zoetis (ZTS) Long-Term Debt Issuances (2013 - 2025) Analysis & Trends

Zoetis (ZTS) has reported Long-Term Debt Issuances for 3 consecutive years, with $152.0 million the latest figure, recorded in Q4 2025.

In Q4 2025, Long-Term Debt Issuances changed N/A year-over-year to $152.0 million; the TTM figure through Dec 2025 stood at $152.0 million (changed N/A YoY), while the FY2025 annual figure was $2.0 billion, changed N/A from the prior year.
Long-Term Debt Issuances improved to $152.0 million in Q4 2025 per ZTS's latest filing, from $11.0 million in the prior quarter.
Across five years, Long-Term Debt Issuances topped out at $152.0 million in Q4 2025 and bottomed at $152.0 million in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Long-Term Debt Issuances (Qtr)
1	Haleon	43.85 Bn	42.88 Bn	-	-
2	Teva Pharmaceutical Industries	43.31 Bn	39.66 Bn	2.15 Bn	-
3	Zoetis	31.65 Bn	29.98 Bn	1.05 Bn	-
4	Takeda Pharmaceutical	28.68 Bn	22.88 Bn	5.10 Bn	-
5	United Therapeutics	22.18 Bn	19.52 Bn	683.80 Mn	-
6	Viatris	18.82 Bn	17.94 Bn	1.46 Bn	-
7	Neurocrine Biosciences	15.70 Bn	15.31 Bn	935.80 Mn	-
8	Elanco Animal Health	12.11 Bn	11.58 Bn	798.00 Mn	-
9	Dr Reddys Laboratories	10.13 Bn	9.96 Bn	-	-
10	Alkermes	8.21 Bn	7.55 Bn	397.90 Mn	-

Download Data